Use of Aerosolized Antibiotics for Treating Chronic Obstructive Pulmonary Disease
AssigneeMpex Pharmaceuticals, Inc.
InventorsMichael N. Dudley, Neil Berkley, David C. Griffith, Jeffery S. Loutit, Elizabeth E. Morgan, Keith A. Bostian, Sanjay Sethi
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compositions for treating obstructive pulmonary disorders. In particular, compositions and methods described herein relate to the use of an aerosolized antibiotic for treating obstructive pulmonary disorders including chronic obstructive pulmonary disorder (COPD) and chronic bronchitis (CB).
Claims31
A method for reducing a rate of acute exacerbations of a pulmonary disorder in a human having said disorder, comprising administering to said human an aerosol of a solution comprising levofloxacin or ofloxacin, wherein the rate of exacerbations in said human is reduced to less than about 6 exacerbations/patient year.
Dependencies are inferred from the claim text.